课题基金 / 基金详情

项目摘要

项目成果

Jann N. Sarkaria的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – BIOSPECIMENS CORE The Biospecimens Core will serve as a central resource to coordinate provision of highly translationally relevant animal and human analytical specimens for use in both main research projects and likely several of the anticipated pilot projects. To maximize the translation relevance of the analyses performed on animal specimens, patient-derived xenografts (PDXs) and genetically engineered mouse models (GEMMs) of glioblastoma (GBM) will be used for our pre-clinical studies. We have extensive experience using these models for evaluating the systems biology of intracranial tumors and how pharmacologic manipulations dysregulate critical signaling nodes within these systems. Coupled with these preclinical studies, analysis of operative specimens from GBM patients provides a ‘ground-truth’ for the biological modeling performed. In this context, the Biospecimens Core will capitalize on established collaborations with neurosurgeons at both DFCI and Mayo Clinic and the extensive Neuro-Oncology Biobank available at Mayo Clinic for provision of both archived tumor samples and prospective analysis of image-registered, fresh operative specimens. Derivative cell, organoid, and tissue-slice cultures from both animal and human biospecimens also will be used to enable reverse translation of key findings and to further refine or validate our systems analyses. To capitalize on opportunities for coordinated analyses of the same biological samples across both Projects, a Scientific Manager will coordinate biospecimen collection, quality assurance review, shipment and analyses across laboratories and projects. The Core also will ensure appropriate regulatory review and approvals are in place to support both the animal and human biospecimen collections and analyses. The overall efforts of the Core can be divided into two Aims to support animal and human GBM studies. Specific Aim 1: Develop, manage, and execute in vivo studies in tumor-bearing animals Specific Aim 2: Coordinate the collection and distribution of human biospecimens
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of the brain penetrant ATM inhibitor WSD0628 in combination with radiation for recurrent high grade glioma
  • 批准号:
    10730230
  • 项目类别:
  • 资助金额:
    $64.93万
  • 财政年份:
    2023
  • 负责人:
    Jann N. Sarkaria
  • 依托单位:
Administrative Core
  • 批准号:
    10305362
  • 项目类别:
  • 资助金额:
    $12.11万
  • 财政年份:
    2021
  • 负责人:
    Jann N. Sarkaria
  • 依托单位:
Therapy Evaluation Core
  • 批准号:
    10704626
  • 项目类别:
  • 资助金额:
    $33.92万
  • 财政年份:
    2021
  • 负责人:
    Jann N. Sarkaria
  • 依托单位:
MDM2 inhibitor therapy for TP53 wild-type GBM
  • 批准号:
    10305366
  • 项目类别:
  • 资助金额:
    $17.28万
  • 财政年份:
    2021
  • 负责人:
    Jann N. Sarkaria
  • 依托单位:
海外基金